LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 61 filers reported holding LEAP THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,524,694 | +902.4% | 7,425,570 | +1226.7% | 0.01% | +600.0% |
| Q4 2022 | $251,867 | -48.9% | 559,705 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $493,000 | -23.4% | 559,705 | 0.0% | 0.00% | -25.0% |
| Q2 2022 | $644,000 | -34.2% | 559,705 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $979,000 | -46.0% | 559,705 | 0.0% | 0.01% | -33.3% |
| Q4 2021 | $1,813,000 | -19.2% | 559,705 | 0.0% | 0.01% | -10.0% |
| Q3 2021 | $2,244,000 | +144.4% | 559,705 | 0.0% | 0.01% | +150.0% |
| Q2 2021 | $918,000 | -13.6% | 559,705 | 0.0% | 0.00% | -20.0% |
| Q1 2021 | $1,063,000 | -15.6% | 559,705 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $1,259,000 | +13.6% | 559,705 | 0.0% | 0.01% | +25.0% |
| Q3 2020 | $1,108,000 | -45.8% | 559,705 | -42.8% | 0.00% | -55.6% |
| Q2 2020 | $2,045,000 | +32.3% | 978,454 | 0.0% | 0.01% | -10.0% |
| Q1 2020 | $1,546,000 | +41.1% | 978,454 | 0.0% | 0.01% | +66.7% |
| Q4 2019 | $1,096,000 | -4.3% | 978,454 | 0.0% | 0.01% | -25.0% |
| Q3 2019 | $1,145,000 | – | 978,454 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 904,600 | $2,035,000 | 1.08% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 275,000 | $619,000 | 0.36% |
| Perceptive Advisors | 8,476,496 | $19,072,000 | 0.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $1,800,000 | 0.16% |
| Golden Green, Inc. | 69,580 | $157,000 | 0.15% |
| Artal Group S.A. | 3,000,000 | $6,750,000 | 0.14% |
| HHLR ADVISORS, LTD. | 3,716,240 | $8,362,000 | 0.07% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,065,259 | $2,397,000 | 0.06% |
| Windsor Creek Advisors, LLC | 89,972 | $202,000 | 0.05% |
| PERSONAL CFO SOLUTIONS, LLC | 73,165 | $165,000 | 0.04% |